Here's Why Sorrento Therapeutics Skyrocketed 24% Higher in June

Here's Why Sorrento Therapeutics Skyrocketed 24% Higher in June

Shares of Sorrento Therapeutics (NASDAQ: SRNE) jumped 24.4% in June, according to data from S&P Global Market Intelligence, as the biotech made progress on its COVID-19 programs. In May, the biotech announced preclinical data for STI-1499, an antibody targeting SARS-CoV-2. The preclinical data drove shares even higher during the first week of July.